HTI
CELG

Hikari Tsushin Inc’s Celgene Corp CELG Stock Holding History

Hikari Tsushin Inc’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-33,782
Closed -$2.68M – 56
2018
Q2 		$2.68M Hold
33,782
– – 0.7% 20
2018
Q1 		$3.01M Hold
33,782
– – 0.79% 19
2017
Q4 		$3.52M Buy
+33,782
New +$3.81M 0.92% 19

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hikari Tsushin Inc's CELG Position: Q3 2018 in Review

Hikari Tsushin Inc sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 33,782 shares — an estimated $2.68M sold.

Hikari Tsushin Inc first reported a position in CELG in Q4 2017 and held it in 3 quarters. The position peaked at $3.52M in Q4 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Hikari Tsushin Inc reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Hikari Tsushin Inc sold 33,782 Celgene Corp shares in Q3 2018, an estimated $2.68M.
  • Hikari Tsushin Inc first reported a position in Celgene Corp in Q4 2017 and held it in 3 quarters.
  • Hikari Tsushin Inc's Celgene Corp position peaked at $3.52M in Q4 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Hikari Tsushin Inc's 13F filing for Q3 2018, filed 15 Nov 2018.